FiteBac Dental
Developer of antimicrobial dental material technologies based on quaternary ammonium silane chemistry. The company focuses on incorporating covalently-bound antimicrobial monomers into dental polymers to reduce microbial colonization, improve adhesive interactions with dentin, and provide antimicrobial properties in restoratives, sealants, and acrylic appliances. Activities include preclinical testing, randomized clinical evaluation, regulatory 510(k) submissions, and a product pipeline spanning cavity cleansers, adhesives, sealants, and irrigants.
Industries
Nr. of Employees
small (1-50)
FiteBac Dental
Marietta, Georgia, United States, North America
Products
Antimicrobial Cavity Cleanser
A 2% quaternary ammonium silane (K21 QAS) aqueous ethanol solution intended for cleansing and moistening cavity preparations; designed to remove carious debris, penetrate dentin tubules, and provide antimicrobial action against oral microorganisms.
FT Bond (adhesive)
A permanent acrylic-based dental adhesive formulation containing 5% K18 (quaternary ammonium silane) designed to resist biofilm formation and loss of adhesion under restorations. (Development status: 510(k) submission reported.)
CC Ortho-Seal (sealant)
A dental enamel sealant formulation containing 5% K18 intended for application prior to orthodontic bracket adhesive to reduce biofilm formation and white spot lesions around brackets. (Development status: 510(k) submitted.)
K18/MMA Liquid (antimicrobial acrylic component)
A liquid component containing K18 quaternary ammonium silane intended for incorporation into MMA/PMMA acrylic resins to confer antimicrobial properties and improve fracture toughness.
FT Endodontic Sealant (in development)
Endodontic sealant in development leveraging antimicrobial silane chemistry for root canal sealing applications.
UD Endodontic Irrigant (in development)
Endodontic irrigant under development based on antimicrobial silane technology for use during root canal procedures.
Antimicrobial Cavity Cleanser
A 2% quaternary ammonium silane (K21 QAS) aqueous ethanol solution intended for cleansing and moistening cavity preparations; designed to remove carious debris, penetrate dentin tubules, and provide antimicrobial action against oral microorganisms.
FT Bond (adhesive)
A permanent acrylic-based dental adhesive formulation containing 5% K18 (quaternary ammonium silane) designed to resist biofilm formation and loss of adhesion under restorations. (Development status: 510(k) submission reported.)
CC Ortho-Seal (sealant)
A dental enamel sealant formulation containing 5% K18 intended for application prior to orthodontic bracket adhesive to reduce biofilm formation and white spot lesions around brackets. (Development status: 510(k) submitted.)
K18/MMA Liquid (antimicrobial acrylic component)
A liquid component containing K18 quaternary ammonium silane intended for incorporation into MMA/PMMA acrylic resins to confer antimicrobial properties and improve fracture toughness.
FT Endodontic Sealant (in development)
Endodontic sealant in development leveraging antimicrobial silane chemistry for root canal sealing applications.
UD Endodontic Irrigant (in development)
Endodontic irrigant under development based on antimicrobial silane technology for use during root canal procedures.
Expertise Areas
- Antimicrobial polymer chemistry
- Dental materials development and testing
- Clinical evaluation of dental biomaterials
- Regulatory submissions for dental devices (510(k))
Key Technologies
- Quaternary ammonium silane (QAMS) chemistry
- Acrylate-functional silane monomers for co-polymerization
- MMA/PMMA acrylic resin modification
- In vitro multi-species biofilm assays
News & Updates
Pivotal clinical trial evaluating in vivo antimicrobial efficacy of QAMS-containing orthodontic acrylic using removable retainers to create 48-hour multi-species plaque biofilms.
Downloadable randomized clinical trial results evaluating antimicrobial activity of a QAMS-containing acrylic resin.
A QAMS antimicrobial component has received FDA 510(k) clearance for use in certain dental appliance resins.
Patent protection stated for the antimicrobial silane chemistries through 2033.
Pivotal clinical trial evaluating in vivo antimicrobial efficacy of QAMS-containing orthodontic acrylic using removable retainers to create 48-hour multi-species plaque biofilms.
Downloadable randomized clinical trial results evaluating antimicrobial activity of a QAMS-containing acrylic resin.
A QAMS antimicrobial component has received FDA 510(k) clearance for use in certain dental appliance resins.
Patent protection stated for the antimicrobial silane chemistries through 2033.